Literature DB >> 20039324

Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.

Shinya Shibutani1, Radha R Bonala, Thomas Rosenquist, Robert Rieger, Naomi Suzuki, Francis Johnson, Frederick Miller, Arthur P Grollman.   

Abstract

Ingestion of aristolochic acids (AA) contained in herbal remedies results in aristolochic acid nephropathy (AAN), which is characterized by chronic renal failure, tubulointerstitial fibrosis and urothelial cancer. AA I and AA II, primary components in AA, have similar genotoxic potential, whereas only AA I shows severe renal toxicity in rodents. AA I is demethylated to form 8-hydroxy-aristolochic acid I (AA Ia) as a major metabolite. However, the nephrotoxicity and genotoxicity of AA Ia has not yet been determined. AA Ia was isolated from urine collected from rats treated with AA I and characterized by NMR and mass spectrometry. The purified AA Ia was administered intraperitoneally to C3H/He male mice for 9 days and its toxicity was compared with AA I. Using (32)P-postlabeling/polyacrylamide gel electrophoresis, the level of AA Ia-derived DNA adducts in renal cortex was approximately 70-110 times lower than that observed with AA I, indicating that AA Ia has only a limited genotoxicity. Supporting this result, when calf thymus DNA was reacted with AA Ia in a buffer containing zinc dust, the formation of AA Ia-DNA adducts was two-orders of magnitude lower than that of AA I. Histopathologic analysis revealed that unlike AA I, no significant changes were detected in the renal cortex of mice treated with AA Ia. Therefore, the contribution of AA Ia to renal toxicity is minimum. We conclude the metabolic pathway of converting AA I to AA Ia functions as the detoxification of AA I.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039324      PMCID: PMC4226239          DOI: 10.1002/ijc.25141

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.

Authors:  Frédéric D Debelle; Joëlle L Nortier; Eric G De Prez; Christian H Garbar; Anne R Vienne; Isabelle J Salmon; Monique M Deschodt-Lanckman; Jean-Louis Vanherweghem
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

2.  Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

Authors:  M Stiborová; M Hájek; E Frei; H H Schmeiser
Journal:  Gen Physiol Biophys       Date:  2001-12       Impact factor: 1.512

3.  Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Authors:  J L Nortier; M C Martinez; H H Schmeiser; V M Arlt; C A Bieler; M Petein; M F Depierreux; L De Pauw; D Abramowicz; P Vereerstraeten; J L Vanherweghem
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

4.  Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.

Authors:  Marie Stiborová; Eva Frei; Bruno Sopko; Manfred Wiessler; Heinz H Schmeiser
Journal:  Carcinogenesis       Date:  2002-04       Impact factor: 4.944

5.  Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology.

Authors:  U Mengs; C D Stotzem
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Acute nephrotoxicity of aristolochic acids in mice.

Authors:  Noriko Sato; Daisuke Takahashi; Shih-Ming Chen; Reiko Tsuchiya; Takuya Mukoyama; Shin-ichi Yamagata; Makoto Ogawa; Masaaki Yoshida; Seizo Kondo; Nobunori Satoh; Shiro Ueda
Journal:  J Pharm Pharmacol       Date:  2004-02       Impact factor: 3.765

Review 7.  Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.

Authors:  Volker M Arlt; Marie Stiborova; Heinz H Schmeiser
Journal:  Mutagenesis       Date:  2002-07       Impact factor: 3.000

Review 8.  Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities.

Authors:  Vineet Kumar; Ashok K Prasad; Virinder S Parmar
Journal:  Nat Prod Rep       Date:  2003-12       Impact factor: 13.423

9.  DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy.

Authors:  Graham M Lord; Monica Hollstein; Volker M Arlt; Candice Roufosse; Charles D Pusey; Terry Cook; Heinz H Schmeiser
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

Review 10.  Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).

Authors:  J L Nortier; J L Vanherweghem
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

View more
  17 in total

1.  Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.

Authors:  Bojan Jelaković; Sandra Karanović; Ivana Vuković-Lela; Frederick Miller; Karen L Edwards; Jovan Nikolić; Karla Tomić; Neda Slade; Branko Brdar; Robert J Turesky; Želimir Stipančić; Damir Dittrich; Arthur P Grollman; Kathleen G Dickman
Journal:  Kidney Int       Date:  2011-11-09       Impact factor: 10.612

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  Aristolochic acid I metabolism in the isolated perfused rat kidney.

Authors:  Horacio A Priestap; M Cecilia Torres; Robert A Rieger; Kathleen G Dickman; Tomoko Freshwater; David R Taft; Manuel A Barbieri; Charles R Iden
Journal:  Chem Res Toxicol       Date:  2011-12-14       Impact factor: 3.739

4.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

5.  Physiological and molecular characterization of aristolochic acid transport by the kidney.

Authors:  Kathleen G Dickman; Douglas H Sweet; Radha Bonala; Tapan Ray; Amy Wu
Journal:  J Pharmacol Exp Ther       Date:  2011-05-05       Impact factor: 4.030

6.  Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.

Authors:  Thomas A Rosenquist; Heidi J Einolf; Kathleen G Dickman; Lai Wang; Amanda Smith; Arthur P Grollman
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

7.  Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.

Authors:  Keiji Hashimoto; Irina N Zaitseva; Radha Bonala; Sivaprasad Attaluri; Katherine Ozga; Charles R Iden; Francis Johnson; Masaaki Moriya; Arthur P Grollman; Viktoriya S Sidorenko
Journal:  Carcinogenesis       Date:  2016-04-18       Impact factor: 4.944

8.  Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.

Authors:  Jingjing Wan; Ruixue Chen; Zhou Yang; Jing Xi; Yiyi Cao; Yu Chen; Xinyu Zhang; Yang Luan
Journal:  Arch Toxicol       Date:  2021-07-05       Impact factor: 5.153

9.  A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.

Authors:  Marie Stiborová; František Bárta; Kateřina Levová; Petr Hodek; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

10.  Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo.

Authors:  Helena Dračínská; František Bárta; Kateřina Levová; Alena Hudecová; Michaela Moserová; Heinz H Schmeiser; Klaus Kopka; Eva Frei; Volker M Arlt; Marie Stiborová
Journal:  Toxicology       Date:  2016-02-01       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.